Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MGX

Metagenomi Inc

Mar 27 • 01:32PM ET

1.53

Dollar change -0.06
Percentage change -3.46	%

Healthcare • Biotechnology • USA • NASD

Peers: NTLA CRSP EDIT BEAM VERV PRME DNLI VRTX SGMO ARCT

| Held by: VTI IWM VXF VTWO IWO IWN IWC VTWG RSSL VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.61	Insider Own	41.49%	Shs Outstand	37.42M	Perf Week	-8.63%
Market Cap	57.38M	Forward P/E	-	EPS next Y	-2.15	Insider Trans	-0.03%	Shs Float	21.87M	Perf Month	-29.26%
Income	-78.06M	PEG	-	EPS next Q	-0.64	Inst Own	27.17%	Short Float	12.05%	Perf Quarter	-61.72%
Sales	52.30M	P/S	1.10	EPS this Y	-3.19%	Inst Trans	-7.94%	Short Ratio	2.78	Perf Half Y	-27.59%
Book/sh	6.28	P/B	0.24	EPS next Y	11.69%	ROA	-22.64%	Short Interest	2.64M	Perf Year	-86.23%
Cash/sh	6.64	P/C	0.23	EPS next 5Y	-16.92%	ROE	-34.69%	52W Range	1.56 - 11.80	Perf YTD	-57.48%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-28.38%	52W High	-86.99%	Beta	-1.04
Dividend TTM	-	Quick Ratio	6.91	Sales past 5Y	2385.08%	Gross Margin	89.66%	52W Low	-1.68%	ATR (14)	0.15
Dividend Ex-Date	-	Current Ratio	6.91	EPS Y/Y TTM	57.38%	Oper. Margin	-170.00%	RSI (14)	26.79	Volatility	4.49% 7.53%
Employees	202	Debt/Eq	0.19	Sales Y/Y TTM	16.84%	Profit Margin	-149.26%	Recom	1.40	Target Price	16.67
Option/Short	No / Yes	LT Debt/Eq	0.17	EPS Q/Q	-21.44%	Payout	-	Rel Volume	0.43	Prev Close	1.59
Sales Surprise	4.21%	EPS Surprise	50.59%	Sales Q/Q	-22.46%	Earnings	Mar 17 AMC	Avg Volume	949.24K	Price	1.53
SMA20	-16.34%	SMA50	-32.65%	SMA200	-47.20%	Trades		Volume	263,579	Change	-3.46%

Date	Action	Analyst	Rating Change	Price Target Change
May-07-24	Initiated	H.C. Wainwright	Buy	$10
May-02-24	Downgrade	JP Morgan	Overweight → Neutral	$16 → $6
Mar-05-24	Initiated	Wells Fargo	Overweight	$25
Mar-05-24	Initiated	TD Cowen	Outperform
Mar-05-24	Initiated	JP Morgan	Overweight	$16
Mar-05-24	Initiated	Jefferies	Buy	$23
Mar-05-24	Initiated	Chardan Capital Markets	Buy	$21
Mar-05-24	Initiated	BMO Capital Markets	Outperform	$22

Mar-17-25 04:05PM	Metagenomi Reports Business Updates and Full Year 2024 Financial Results (GlobeNewswire) -7.98%
Mar-13-25 06:19AM	Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems (GlobeNewswire) -6.83%
Feb-11-25 08:55AM	Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -6.17%
Jan-28-25 08:00AM	Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer (GlobeNewswire)
Jan-22-25 11:54AM	People are buying the wrong stock thinking it's part of OpenAI's Stargate Project (Quartz) +11.40%
08:55AM	Loading…
Jan-16-25 08:55AM	Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones (GlobeNewswire)
Jan-15-25 08:55AM	Metagenomi Announces New Appointment to its Board of Directors (GlobeNewswire)
Jan-08-25 04:05PM	Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.36%
Dec-11-24 06:30PM	Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference RNA at the Bench and Bedside IV (GlobeNewswire) -5.73%
Dec-09-24 09:16PM	Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting (GlobeNewswire) +125.41%
Dec-08-24 06:05AM	Jefferies Predicts Up to ~1000% Surge for These 2 Strong Buy Stocks (TipRanks)
Nov-18-24 12:00PM	What Makes Metagenomi (MGX) a New Buy Stock (Zacks)
Nov-13-24 04:37PM	Metagenomi: Q3 Earnings Snapshot (Associated Press Finance) -10.90%
04:05PM	Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 04:05PM	Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting (GlobeNewswire)
05:45AM	Loading…
Oct-29-24 05:45AM	Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Oct-24-24 08:04AM	Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT (GlobeNewswire)
Oct-23-24 05:45AM	Investors in Metagenomi, Inc. Should Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Oct-14-24 08:58PM	Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies (GlobeNewswire)
Oct-01-24 03:14PM	Metagenomi, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Sep-19-24 07:15PM	Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire) -6.84%
Sep-03-24 04:05PM	Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months (GlobeNewswire)
Aug-29-24 07:32PM	Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference (GlobeNewswire)
Aug-28-24 06:10PM	Metagenomi to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.05%
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-14-24 08:11AM	Metagenomi: Q2 Earnings Snapshot (Associated Press Finance)
08:05AM	Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-12-24 06:29PM	Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating From Street Analysts (Insider Monkey) +10.54%
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Metagenomi and Encourages Investors to Contact the Firm (GlobeNewswire)
Jun-03-24 04:30PM	Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? (Insider Monkey)
04:17PM	Loading…
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-29-24 04:00PM	Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-14-24 10:54PM	MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results (GlobeNewswire)
May-04-24 10:49AM	Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace) -12.36%
May-01-24 04:00PM	Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems (GlobeNewswire)
01:53PM	Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight (FierceBiotech.com)
Apr-08-24 08:00AM	Metagenomi to Present at Upcoming Scientific Meetings (GlobeNewswire)
Mar-27-24 09:16AM	Metagenomi Reports Business Updates and Full Year 2023 Financial Results (GlobeNewswire)
Feb-29-24 04:30PM	Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-13-24 04:35PM	Metagenomi Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-08-24 10:16PM	Metagenomi Announces Pricing of Initial Public Offering (GlobeNewswire)

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wein Matthew	See Remarks	Mar 05 '25	Sale	1.87	930	1,744	9,467	Mar 07 04:38 PM
Wapnick Pamela	Chief Financial Officer	Mar 05 '25	Sale	1.87	1,808	3,390	59,684	Mar 07 04:36 PM
Wapnick Pamela	Chief Financial Officer	Dec 05 '24	Sale	1.86	1,559	2,900	61,492	Dec 06 04:24 PM
Wapnick Pamela	Chief Financial Officer	Sep 05 '24	Sale	2.88	6,265	18,043	63,051	Sep 06 05:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MGX

Metagenomi Inc

Upgrade your FINVIZ experience